Suzanne Sharpton

Assistant Professor of Medicine

Vanderbilt University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (2)

Jinho Jung

University of California, San Diego

UNITED STATES

View details

Yuko Kono

University of California, San Diego

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Suzanne Sharpton

Research Interests

Explore related searches

Contact this professor

Articles (13)

Reply: Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC

Editorial: first‐degree relatives of Mexican Americans with HCC are at increased risk of significant fibrosis—authors' reply

Original Article: prevalence and factors associated with liver fibrosis among first-degree relatives of Mexican Americans with hepatocellular carcinoma.

Editorial: Assessing advanced fibrosis in metabolic‐associated steatotic liver disease—The MAFLD fibrosis score

Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC

Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease.

Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease

Clinical Utility of Combined MRI-PDFF and ALT Response in Predicting Histologic Response in Nonalcoholic Fatty Liver Disease.

Gut metagenome-derived signature predicts hepatic decompensation and mortality in NAFLD-related cirrhosis.

Changes in the gut microbiome associated with liver stiffness improvement in nonalcoholic steatohepatitis.

Prognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholic fatty liver disease.

Two-Step Strategy, FIB-4 Followed by Magnetic Resonance Elastography, for Detecting Advanced Fibrosis in NAFLD.

Magnetic resonance elastography plus Fibrosis-4 versus FibroScan-aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH-related fibrosis.

Collaborators (2)

Jinho Jung

Yuko Kono

Make your next move.